Priority Date: 16.08.11 (EP 20110177658)

COMBINATION THERAPY WITH AN ANTI - CD19 ANTIBODY AND A NITROGEN MUSTARD

  • Application ID: EP12747923
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 193 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 16.08.2011 - Priority Date (EP 20110177658)
  • 21.02.2013 - Publication A1 (WO2013024097)
  • 25.06.2014 - Publication A1 (EP2744515)

IPC Classification